Form 4: Rivian CEO Robert Scaringe Executes Stock Option and Sells Shares Under 10b5-1 Plan
SEC Form 4 Filing
Rivian CEO Robert J. Scaringe exercised stock options and sold shares of Class A Common Stock under a pre-arranged Rule 10b5-1 trading plan.
Summary
- On July 8, 2024, Rivian CEO Robert J. Scaringe exercised a stock option to acquire 71,429 shares of Class A Common Stock at a price of $2.6282 per share.
- Simultaneously, Scaringe sold 71,429 shares of Class A Common Stock at a weighted average price of $14.975 per share, with individual sales ranging from $14.68 to $15.20.
- These transactions were executed under a Rule 10b5-1 trading plan adopted on March 8, 2024.
- Following these transactions, Scaringe directly owns 909,691 shares of Class A Common Stock.
- He also indirectly owns 4,595 shares through an LLC and 2,632,766 shares through a trust.
Sentiment
Score: 5
Explanation: The document is a standard SEC Form 4 filing, detailing insider transactions. It doesn't inherently convey positive or negative sentiment, but rather provides factual information about the CEO's stock activity.
Industry Context
Insider transactions, especially those by CEOs, are closely watched by investors for signals about a company's prospects. The use of a 10b5-1 plan suggests the transactions were pre-planned and intended to avoid any appearance of trading on inside information.
Comparison to Industry Standards
- Executive compensation packages often include stock options as a way to align management's interests with those of shareholders.
- Rule 10b5-1 plans are a common tool used by corporate insiders to sell shares without raising concerns about insider trading.
- The volume of shares traded is relatively small compared to the overall market capitalization of Rivian, suggesting it's unlikely to have a significant impact on the stock price.
Stakeholder Impact
- Shareholders may be interested in the CEO's stock transactions as an indicator of management's confidence in the company.
- The transactions themselves are unlikely to have a significant impact on the company's operations or financial performance.
Key Dates
| Date | Description |
|---|---|
| 02/14/2023 | Stock option was fully vested |
| 03/08/2024 | Rule 10b5-1 trading plan adopted |
| 05/07/2024 | Issuer's Quarterly Report on Form 10-Q filed with the SEC |
| 07/08/2024 | Stock option exercised and shares sold |
| 07/10/2024 | Date of signature for the SEC filing |
| 03/15/2029 | Expiration date of stock option |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.